Freeman Jennifer
SEC CIK 1786584 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| PNTG | Pennant Group, Inc. | SVP of Strategic Partnerships | 34.8K | — | $19.0K | 3 | 2022-07-14 | 2023-05-30 |
Most active insiders at PNTG, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Guerisoli Brent | CEO | — | $582.7K |
| 2 | Steik Jason Paul | Chief Clinical Off | — | $53.7K |
| 3 | Cheney Kirk Sterling | EVP, GC, Corp Secy | — | $53.7K |
| 4 | Walbom Lynette | CFO | — | — |
| 5 | Morris Gregory K Sr. | Dir | — | — |
| 6 | Gochnour John J | COO | — | — |
| 7 | Snapper Suzanne D. | Dir | — | — |
| 8 | Nackel John G. | Dir | — | — |
| 9 | Christensen Christopher R. | Dir | — | — |
| 10 | Lamb Scott E | Dir | — | — |
Freeman Jennifer made no open-market trades at PNTG in the last 12 months.
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-01 | 2023-05-30 | PNTG | Pennant Group, Inc. | Freeman Jennifer | SVP of Strategic Partnerships | S - Sale | $11.65 | -611 | 34.8K | -2% | -$7,118 | |
| 2022-07-27 | 2022-07-25 | PNTG | Pennant Group, Inc. | Freeman Jennifer | CFO | A - Grant | $0.00 | +20.0K | 35.4K | +130% | $0 | |
| 2022-07-18 | 2022-07-14 | PNTG | Pennant Group, Inc. | Freeman Jennifer | CFO | S - Sale | $10.75 | -1,102 | 15.4K | -7% | -$11.8K |
Purchase Sale Sale after option exercise All abbreviations